<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Research in 2019 | ARSACS</title>
	<atom:link href="https://arsacs.com/category/research-2019/feed/" rel="self" type="application/rss+xml" />
	<link>https://arsacs.com</link>
	<description>Research That Heals</description>
	<lastBuildDate>Mon, 16 Mar 2026 22:12:18 +0000</lastBuildDate>
	<language>en-CA</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://arsacs.com/wp-content/uploads/2021/02/cropped-FAVICON-32x32.png</url>
	<title>Research in 2019 | ARSACS</title>
	<link>https://arsacs.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Characterization of Tau Hyperphosphorylation in ARSACS &#8211; Dr. Anthony Hickey</title>
		<link>https://arsacs.com/characterization-of-tau-hyperphosphorylation-in-arsacs-dr-anthony-hickey/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Fri, 30 Oct 2020 18:11:19 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/characterization-of-tau-hyperphosphorylation-in-arsacs-dr-anthony-hickey/</guid>

					<description><![CDATA[The goal of this proposal is to validate the misregulation of Tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS. Grant : $98,758 Contact: Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina 120 Mason [...]]]></description>
										<content:encoded><![CDATA[
<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph">The goal of this proposal is to validate the misregulation of Tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS.</p>



<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph">Grant : $98,758</p>



<p class="wp-block-paragraph">Contact:</p>



<div class="wp-block-image"><figure class="alignleft"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Dr.-Anthony-Hickey-150x150-1.jpg" alt="" class="wp-image-6259"/></figure></div>



<p class="wp-block-paragraph">Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina</p>



<p class="wp-block-paragraph"><span style="font-size: inherit;">120 Mason Farm Road </span><span style="font-size: inherit;">CB# 7356, </span><span class="gmail-address-city">Chapel Hill</span><span class="gmail-address-state">&nbsp;NC</span><span class="gmail-address-zip">&nbsp;27599</span></p>



<p class="wp-block-paragraph">Tel: (919)&nbsp;962-9819</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Targeting deregulated calcium homeostasis as potential therapeutic option for ARSACS -Dr. Francesca Maltecca</title>
		<link>https://arsacs.com/targeting-deregulated-calcium-homeostasis-as-potential-therapeutic-option-for-arsacs-dr-francesca-maltecca-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 07 Dec 2019 23:53:58 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/targeting-deregulated-calcium-homeostasis-as-potential-therapeutic-option-for-arsacs-dr-francesca-maltecca/</guid>

					<description><![CDATA[The major aims of this project are: 1) to evaluate the functional role of sacsin at the synaptic level, in particular its involvement in the control of calcium fluxes in Purkinje neurons at the postsynaptic space; 2) to strengthen the evidence of efficacy of an off-label drug regulating calcium homeostasis in ARSACS, by conducting a [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The major aims of this project
are:</p>



<p class="wp-block-paragraph">1) to evaluate the functional
role of sacsin at the synaptic level, in particular its involvement in the
control of calcium fluxes in Purkinje neurons at the postsynaptic space;</p>



<p class="wp-block-paragraph">2) to strengthen the evidence
of efficacy of an off-label drug regulating calcium homeostasis in ARSACS, by
conducting a preclinical trial at post- symptomatic stage in Sacs-/- mice with
a chronic treatment;</p>



<p class="wp-block-paragraph">3) to dissect the mechanism by which this drug rescues ataxia and Purkinje cell degeneration in Sacs-/- mice, by evaluating effects on deregulated calcium homeostasis, NF bundling or faulty mitochondrial transport, integrated with multi-omics approaches.</p>



<p class="wp-block-paragraph">Duration: One year </p>



<p class="wp-block-paragraph">Funding : $100,000</p>



<p class="wp-block-paragraph">Contact: </p>



<figure class="wp-block-image size-large"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/DrFrancescaMaltecca.jpg" alt="Dr. Francesca Maltecca" class="wp-image-234"/></figure>



<p class="wp-block-paragraph">Dr. Francesca Maltecca ,  Ospedale San Raffaele, Milan Italy.</p>



<p class="wp-block-paragraph">email <a rel="noreferrer noopener" href="mailto:maltecca.francesca@unisr.it" target="_blank">maltecca.francesca@unisr.it</a> </p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Is SARM1 a therapeutic target for ARSACS?- Dr. Thomas Schwarz</title>
		<link>https://arsacs.com/is-sarm1-a-therapeutic-target-for-arsacs-dr-thomas-schwarz-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Tue, 26 Nov 2019 20:01:23 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/is-sarm1-a-therapeutic-target-for-arsacs-dr-thomas-schwarz/</guid>

					<description><![CDATA[This project uses the sacsin mutant mouse and mice lacking SARM1 to ask whether the progression of the cell loss in ARSACS can be slowed or prevented by removing SARM1. A positive outcome would make ARSACS a strong candidate for this therapeutic strategy. Duration : 18 months Grant: $144,689 Contact: Dr. Thomas L. Schwarz, Professor, [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong>This project uses the sacsin mutant mouse and mice lacking SARM1 to ask whether the progression of the cell loss in ARSACS can be slowed or prevented by removing SARM1. A positive outcome would make ARSACS a strong candidate for this therapeutic strategy.</strong></p>



<p class="wp-block-paragraph">Duration : 18 months </p>



<p class="wp-block-paragraph">Grant: $144,689 </p>



<p class="wp-block-paragraph">Contact:</p>



<figure class="wp-block-image size-large"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Schwarz.jpg" alt="Dr. Thomas L. Schwarz" class="wp-image-222"/></figure>



<p class="wp-block-paragraph">Dr. Thomas L. Schwarz, Professor, F.M. Kirby Neurobiology Center Children’s Hospital, Boston and Dept.of Neurobiology<br>Harvard Medical School CLSB 12-130, 3 Blackfan Street, Boston, MA 02115<br>Tel:(617)-919-2219 (office) or (617)-919-2264 (lab)</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Is ARSACS a Tauopathy?- Dr. Paul Chapple</title>
		<link>https://arsacs.com/is-arsacs-a-tauopathy-dr-paul-chapple-4/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Wed, 09 Oct 2019 22:08:07 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/is-arsacs-a-tauopathy-dr-paul-chapple/</guid>

					<description><![CDATA[The objectives of the project will be published at a later date Duration: 3 year funded project Grant: 32,827 pounds Contact: Dr.Paul Chapple, Professor of Molecular Cell BiologyCentre for Endocrinology Barts and The London, Queen Mary’s School of Medicine and Dentistry1st Floor North ,John Vane Science Building,Charterhouse SquareLondon, EC1M 6BQT: +44 (0) 20 7882 6242E:&#160;j.p.chapple@qmul.ac.uk]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The objectives of the project will be published at a later date </p>



<p class="wp-block-paragraph">Duration: 3 year funded project </p>



<p class="wp-block-paragraph">Grant: 32,827 pounds</p>



<p class="wp-block-paragraph">Contact: </p>



<figure class="wp-block-image"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/DrPaulChapple.jpg" alt="Dr. Paul Chapple" class="wp-image-274"/></figure>



<p class="wp-block-paragraph">

Dr.Paul Chapple, Professor of Molecular Cell Biology<br>Centre for Endocrinology Barts and The London, Queen Mary’s School of Medicine and Dentistry<br>1st Floor North ,John Vane Science Building,Charterhouse Square<br>London, EC1M 6BQ<br>T: +44 (0) 20 7882 6242<br>E:&nbsp;<a href="mailto:j.p.chapple@qmul.ac.uk">j.p.chapple@qmul.ac.uk</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Towards the Structural Determination of Sacsin- Dr. Walid A. Houry</title>
		<link>https://arsacs.com/towards-the-structural-determination-of-sacsin-dr-walid-a-houry-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 03 Oct 2019 22:13:58 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/towards-the-structural-determination-of-sacsin-dr-walid-a-houry/</guid>

					<description><![CDATA[Aim 1. Engineering cells with tagged SACS for purification Aim 2. Purification and determination of SACS structure Aim3: To purify and determine the structure of Canadian SACS mutants Duration : 2 year project&#160;Grant: $74,000 in year 1Contact: Dr. Walid A. Houry, Department of Biochemistry, Faculty of Medicine, University of Toronto 661 University Avenue Mars Centre, [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Aim 1.
Engineering cells with tagged SACS for purification</p>



<p class="wp-block-paragraph">Aim 2.
Purification and determination of SACS structure</p>



<p class="wp-block-paragraph">Aim3: To
purify and determine the structure of Canadian SACS mutants</p>



<p class="wp-block-paragraph">Duration : 2 year project&nbsp;<br>Grant: $74,000 in year 1<br>Contact:</p>



<figure class="wp-block-image"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Walid_Houry_University_Toronto.jpg" alt="" class="wp-image-6571"/></figure>



<p class="wp-block-paragraph">Dr. Walid A. Houry, Department of Biochemistry, Faculty of
Medicine, University of Toronto<br>
661 University Avenue<br>
Mars Centre, West Tower, Room 1612<br>
Toronto, ON&nbsp; Canada M5G 1M1<br>
Tel: 416 946 7141; Fax: 416 978 8548<br>
Email: walid.houry@utoronto.ca</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Elucidating Mechanisms Underlying Motor Coordination Rescue in a Mouse Model of ARSACS &#8211; Dr. Alanna Watt</title>
		<link>https://arsacs.com/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-alanna-watt-3/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Fri, 27 Jul 2018 21:52:59 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-alanna-watt/</guid>

					<description><![CDATA[Aim 1&#160;Identifying druggable Targets for potential ARSACS treatment Aim 2&#160;Characterize pathophysiology for future druggable target development Duration : 2nd year of the funded projectGrant: $75,000Contacts: Dr. Alanna Watt,Department of Biology McGill University Bellini Life Sciences Bldg.3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1 Office: Rm. 265 &#124; Lab: Rm. 257Tel: (514)-398-2806; Fax: (514)-398-5069; Email: [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong>Aim 1&nbsp;</strong>Identifying druggable Targets for potential ARSACS treatment</p>



<p class="wp-block-paragraph"><strong>Aim 2&nbsp;</strong>Characterize pathophysiology for future druggable target development</p>



<p class="wp-block-paragraph">Duration : 2nd year of the funded project<br>Grant: $75,000<br>Contacts:</p>



<figure class="wp-block-image"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/watt-1-150x150-2.jpg" alt="Dr. Alanna Watt" class="wp-image-132"/></figure>



<p class="wp-block-paragraph">Dr. Alanna Watt,Department of Biology McGill University Bellini Life Sciences Bldg.<br>3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1 Office: Rm. 265 | Lab: Rm. 257<br>Tel: (514)-398-2806; Fax: (514)-398-5069; Email: alanna.watt@mcgill.ca</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Elucidating Mechanisms Underlying Motor Coordination Rescue in a Mouse Model of ARSACS &#8211; Dr. Anne McKinney</title>
		<link>https://arsacs.com/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-anne-mckinney-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 28 Jul 2018 01:52:59 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-anne-mckinney/</guid>

					<description><![CDATA[Aim 1&#160;Identifying druggable Targets for potential ARSACS treatment Aim 2&#160;Characterize pathophysiology for future druggable target development Duration : 2nd year of the funded projectGrant: $50,000Contact: Dr. Anne McKinney, Department of Pharmacology and Therapeutics, McGill University Bellini Life Sciences Bldg3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1Tel: (514)-398-5685; Fax: (514)-398-2045; Email: anne.mckinney@mcgill.ca]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong>Aim 1&nbsp;</strong>Identifying druggable Targets for potential ARSACS treatment</p>



<p class="wp-block-paragraph"><strong>Aim 2&nbsp;</strong>Characterize pathophysiology for future druggable target development</p>



<p class="wp-block-paragraph">Duration : 2nd year of the funded project<br>Grant: $50,000<br>Contact:</p>



<figure class="wp-block-image"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Anne-McKinney-150x150-2.jpg" alt="Dr. Anne McKinney" class="wp-image-186"/></figure>



<p class="wp-block-paragraph">Dr. Anne McKinney, Department of Pharmacology and Therapeutics, McGill University Bellini Life Sciences Bldg<br>3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1<br>Tel: (514)-398-5685; Fax: (514)-398-2045; Email: anne.mckinney@mcgill.ca</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sacin’s role in Synapses: Early Pathological Changes in ARSACS- Dr. Bernard Brais</title>
		<link>https://arsacs.com/sacins-role-in-synapses-early-pathological-changes-in-arsacs-dr-bernard-brais-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 28 Jul 2018 01:50:22 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/sacins-role-in-synapses-early-pathological-changes-in-arsacs-dr-bernard-brais/</guid>

					<description><![CDATA[Aim 1: Sacsin’s role in dendritic spines morphology Aim 1.1.&#160;Assess the impact of sacsin loss on dendritic spines morphology Aim 1.2.&#160;Assess the role of sacsin partners on dendritic spine morphology. Aim 1.3.&#160;Study spine morphology in Sacs-/-&#160;mice. Aim 1.4.&#160;Assess the role of sacsin on receptor internalization Grant $100,000 Contact Dr. Bernard Brais Dr. Bernard Brais, co-director [...]]]></description>
										<content:encoded><![CDATA[
<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph"><b>Aim 1: Sacsin’s role in dendritic spines morphology<u></u><u></u></b></p>



<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph"><b>Aim 1.1</b>.&nbsp;<i>Assess the impact of sacsin loss on dendritic spines morphology<u></u><u></u></i></p>



<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph"><b>Aim 1.2.&nbsp;</b><i>Assess the role of sacsin partners on dendritic spine morphology.<u></u><u></u></i></p>



<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph"><b>Aim 1.3.&nbsp;</b><i>Study spine morphology in Sacs</i><i>-/-&nbsp;</i><i>mice.<u></u><u></u></i></p>



<p class="m_-2151711370727717155MsoListParagraph wp-block-paragraph"><b>Aim 1.4.&nbsp;</b><i>Assess the role of sacsin on receptor internalization</i></p>



<p class="wp-block-paragraph">Grant $100,000</p>



<p class="wp-block-paragraph">Contact</p>



<div class="wp-block-image size-thumbnail wp-image-192"><figure class="alignleft"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Brais_2015-150x150-2.jpg" alt="Dr. Bernard Brais" class="wp-image-192"/><figcaption>Dr. Bernard Brais</figcaption></figure></div>



<p class="wp-block-paragraph">Dr. Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital<br>3801 University Street Montreal, Quebec, Canada H3A 2B4<br>Tel:(514)-398-3334; Email: bernard.brais@mcgill.ca</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Optimization of Active Molecules Towards a Pre-Clinical in Vivo Proof of Mechanism of ARSACS Phenotype Reversal &#8211; Dr. Michel Bouvier</title>
		<link>https://arsacs.com/optimization-of-active-molecules-towards-a-pre-clinical-in-vivo-proof-of-mechanism-of-arsacs-phenotype-reversal-dr-michel-bouvier-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 28 Jul 2018 01:46:58 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/optimization-of-active-molecules-towards-a-pre-clinical-in-vivo-proof-of-mechanism-of-arsacs-phenotype-reversal-dr-michel-bouvier/</guid>

					<description><![CDATA[The goal is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and/or lead to clinical improvement. Grant: $160,000 Contact Dr.Michel Bouvier, Institute for Research in Immunology and Cancer (IRIC)IRIC &#124; Université de Montréal C.P. 6128, succursale Centre-ville, Montréal (Québec) H3C 3J7Tel: [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The goal is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and/or lead to clinical improvement.</p>



<p class="wp-block-paragraph">Grant: $160,000</p>



<p class="wp-block-paragraph">Contact</p>



<div class="wp-block-image"><figure class="alignleft"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/Michel_Bouvier-1-150x150-2.jpg" alt="" class="wp-image-3353"/></figure></div>



<p class="wp-block-paragraph">Dr.Michel Bouvier, Institute for Research in Immunology and Cancer (IRIC)<br>IRIC | Université de Montréal C.P. 6128, succursale Centre-ville, Montréal (Québec) H3C 3J7<br>Tel: (514)-343-6319 ; Email: michel.bouvier@umontreal.ca</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Therapeutic Approaches for ARSACS- Dr. Benoit Gentil</title>
		<link>https://arsacs.com/therapeutic-approaches-for-arsacs-dr-benoit-gentil-3/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 28 Jul 2018 01:43:08 +0000</pubDate>
				<category><![CDATA[Research in 2019]]></category>
		<guid isPermaLink="false">https://clone.arsacs.com/therapeutic-approaches-for-arsacs-dr-benoit-gentil/</guid>

					<description><![CDATA[To obtain preclinical proof-of-concept for ARSACS treatments based on: 1) a protein/gene replacement approach and&#160; 2) drug treatment using HDAC inhibitors. Grant: $100,000 Contact Dr. Benoit Gentil, Department of Kinesiology and Physical Education, McGill University475 Pine Avenue West, room 210, Montreal, Quebec&#160; H3A 2B4 Tel: 514-398-4184 ext 00102&#160; email:benoit.gentil@mcgill.ca]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">To obtain preclinical proof-of-concept for ARSACS treatments based on:</p>



<p class="wp-block-paragraph">1) a protein/gene replacement approach and&nbsp;</p>



<p class="wp-block-paragraph">2) drug treatment using HDAC inhibitors.</p>



<p class="wp-block-paragraph">Grant: $100,000</p>



<p class="wp-block-paragraph">Contact</p>



<div class="wp-block-image"><figure class="alignleft"><img decoding="async" src="https://arsacs.com/wp-content/uploads/2021/02/benoitgentil-150x150-1.jpg" alt="" class="wp-image-6218"/></figure></div>



<p class="wp-block-paragraph">Dr. Benoit Gentil, Department of Kinesiology and Physical Education, McGill University<br>475 Pine Avenue West, room 210, Montreal, Quebec&nbsp; H3A 2B4</p>



<p class="wp-block-paragraph">Tel: 514-398-4184 ext 00102&nbsp; email:benoit.gentil@mcgill.ca</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
